Profile data is unavailable for this security.
About the company
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
- Revenue in EUR (TTM)1.16bn
- Net income in EUR90.59m
- Incorporated2017
- Employees3.60k
- LocationDermapharm Holding SELil-Dagover-Ring 7GRUENWALD 82031GermanyDEU
- Phone+49 89641860
- Fax+49 8 964186130
- Websitehttps://ir.dermapharm.de/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vimian Group AB | 352.02m | 255.73k | 1.89bn | 1.10k | 8,517.80 | 2.87 | 55.30 | 5.38 | 0.005 | 0.005 | 8.34 | 14.84 | 0.3401 | 2.85 | 6.75 | 3,720,738.00 | 0.0938 | -- | 0.1025 | -- | 46.88 | -- | 0.2758 | -- | 2.18 | 2.06 | 0.2734 | -- | 17.92 | -- | 245.95 | -- | -- | -- |
| Chongqing Taiji Industry Group Co Ltd | 1.82bn | 79.72m | 1.91bn | 12.59k | 23.90 | 3.64 | -- | 1.05 | 1.09 | 1.09 | 24.91 | 7.18 | 0.9696 | 2.82 | 5.08 | 1,102,051.00 | 4.46 | 0.7814 | 12.44 | 2.35 | 42.31 | 44.03 | 4.60 | 0.8498 | 0.4665 | 5.50 | 0.5528 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Bonesupport Holding AB | 70.05m | 7.79m | 1.92bn | 131.00 | 248.93 | 34.19 | 220.77 | 27.41 | 1.36 | 1.36 | 12.29 | 9.92 | 1.16 | 0.6138 | 5.62 | 7,756,762.00 | 12.85 | -9.08 | 14.98 | -11.28 | 92.43 | 90.25 | 11.12 | -11.65 | 3.50 | -- | 0.0222 | -- | 79.76 | 43.65 | 459.44 | -- | 18.39 | -- |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 160.05m | 47.61m | 1.93bn | 965.00 | 40.49 | 2.90 | -- | 12.04 | 0.5897 | 0.5897 | 1.98 | 8.23 | 0.2214 | 1.54 | 6.63 | 1,267,186.00 | 6.36 | 1.32 | 6.97 | 1.41 | 75.73 | 80.74 | 28.72 | 6.55 | 3.24 | -- | 0.0098 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Grand Pharmaceutical Group Ltd | 1.29bn | 293.48m | 1.97bn | 10.78k | 6.62 | 1.03 | 5.63 | 1.53 | 0.6885 | 0.6885 | 3.03 | 4.43 | 0.4472 | 3.62 | 4.54 | 1,005,064.00 | 10.25 | 10.09 | 14.21 | 14.01 | 59.00 | 61.97 | 22.92 | 22.35 | 1.09 | -- | 0.2232 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
| Dermapharm Holding SE | 1.16bn | 90.59m | 1.99bn | 3.60k | 21.96 | 3.40 | 10.56 | 1.71 | 1.68 | 1.68 | 21.48 | 10.84 | 0.5412 | 1.20 | 9.41 | 331,396.30 | 4.17 | 8.68 | 5.01 | 10.06 | 64.66 | 61.94 | 7.71 | 12.31 | 0.7368 | 3.23 | 0.6352 | 54.69 | 10.79 | 14.68 | -53.54 | -3.70 | 9.85 | -- |
| Ligand Pharmaceuticals Inc | 144.56m | 42.91m | 2.00bn | 58.00 | 45.97 | 2.49 | 26.10 | 13.83 | 2.43 | 2.43 | 8.25 | 44.84 | 0.1768 | 0.4689 | 4.34 | 2,627,966.00 | 5.25 | 12.32 | 5.37 | 12.99 | 93.52 | 81.65 | 29.68 | 80.32 | 11.81 | -- | 0.00003 | -- | -33.09 | -12.18 | 1,131.21 | -17.86 | 42.63 | -- |
| Jubilant Pharmova Ltd | 777.90m | 66.67m | 2.01bn | 995.00 | 30.24 | 3.01 | 18.53 | 2.59 | 37.38 | 37.38 | 436.41 | 375.04 | 0.5934 | 1.75 | 8.15 | 69,544,720.00 | 5.05 | 2.96 | 6.01 | 3.55 | 68.50 | 68.47 | 8.51 | 5.13 | 1.20 | 2.51 | 0.342 | 24.73 | 6.70 | -5.95 | 226.43 | -33.08 | 6.48 | 2.13 |
| Amphastar Pharmaceuticals Inc | 686.22m | 149.59m | 2.02bn | 1.76k | 14.67 | 2.93 | 10.10 | 2.95 | 3.01 | 3.01 | 13.79 | 15.04 | 0.4684 | 2.83 | 5.60 | 410,873.90 | 10.28 | 9.42 | 11.88 | 11.56 | 52.98 | 47.83 | 21.95 | 15.23 | 2.61 | 9.42 | 0.4506 | 0.00 | 29.14 | 16.94 | 50.51 | -- | -4.00 | -- |
| Bavarian Nordic A/S | 813.65m | 149.95m | 2.04bn | 1.61k | 13.45 | 1.41 | 8.85 | 2.51 | 14.36 | 14.36 | 78.05 | 136.86 | 0.4439 | 1.47 | 5.52 | 4,401,443.00 | 8.18 | 1.21 | 10.46 | 1.48 | 52.38 | 53.72 | 18.43 | 4.06 | 0.976 | -- | 0.0106 | 0.00 | 124.14 | 69.78 | 524.66 | -- | 35.76 | -- |
